Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 18/20 | 0.63 |
| ▸ | LCK | P06239 | 5/20 | 0.63 |
| ▸ | ITK | Q08881 | 5/20 | 0.63 |
| ▸ | EGFR | P00533 | 4/20 | 0.63 |
| ▸ | JAK3 | P52333 | 4/20 | 0.63 |
| ▸ | NUDT14 | O95848 | 1/20 | 0.57 |
| ▸ | NUDT5 | Q9UKK9 | 1/20 | 0.57 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.54 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.54 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.54 |
| ▸ | PRKDC | P78527 | 1/20 | 0.54 |
| ▸ | BMX | P51813 | 3/20 | 0.50 |
| ▸ | FYN | P06241 | 2/20 | 0.50 |
| ▸ | YES1 | P07947 | 1/20 | 0.49 |
| ▸ | LYN | P07948 | 1/20 | 0.49 |
| ▸ | HCK | P08631 | 1/20 | 0.49 |
| ▸ | FGR | P09769 | 1/20 | 0.49 |
| ▸ | SRC | P12931 | 1/20 | 0.49 |
| ▸ | FLT3 | P36888 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27019885 | 0.85 | PIK3CD (0.72) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL410078 | 0.82 | BTK (0.75) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL410076 | 0.82 | BTK (0.72) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL27019883 | 0.81 | NUDT14 (0.66) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL13861437 | 0.81 | BTK (0.72) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL29665672 | 0.81 | BTK (0.72) | BTKLCKITKEGFRJAK3 | |
| Hydrochloric Acid SCHEMBL29665759 | 0.80 | BTK (0.70) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL25479854 | 0.79 | BTK (0.69) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL15686218 | 0.79 | BTK (0.61) | BTKLCKITKEGFRJAK3 | |
| SCHEMBL25069017 | 0.79 | NUDT14 (0.68) | BTKLCKITKEGFRJAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100138-A1 | THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | PHARMACYCLICS, INC. (US) | 2012-04-26 | — | — | US | disclosed |
| US-20120100138-A1 | THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | PHARMACYCLICS, INC. (US) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100138-A1 | THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | BTK, SYK, LYN | BTK 1/4885LCK 5/4885ITK 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.